Tumor
ADC is a More Accurate Biomarker of Tumor Burden than T1, T2, or FLAIR in Primary Glioma
Damian E. Teasley, BS
Medical StudentDepartment of Neurological Surgery, Columbia University Irving Medical CenterSalem, Utah, United States